stella
beta
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia — Stella
Home
/
Hereditary Hemorrhagic Telangiectasia
/
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
View on ClinicalTrials.gov
Recruiting
Back to Hereditary Hemorrhagic Telangiectasia trials
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(18 sites)
France
CHU d'Angers, Angers
CHU de Bordeaux, Bordeaux
Hôpital Ambroise Paré, Boulogne-Billancourt
CHU de Caen Normandie, Caen
CHU clermont-ferrand, Clermont-Ferrand
CHU de Dijon, Dijon
CHRU de Lille, Lille
Hospices Civiles de Lyon, Lyon
Assistance Publique - Hôpitaux de Marseille, Marseille
CHU de Montpellier, Montpellier
CHU de Nancy, Nancy
CHU de Nantes, Nantes
CHU de Nice, Nice
AP-HP - Hôpital Ténon, Paris
CHU de Poitiers, Poitiers
CHU de Rennes, Rennes
CHRU de Strasbourg, Strasbourg
CHU de Toulouse, Toulouse